Nusa Raya Cipta Tbk PT
IDX:NRCA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nusa Raya Cipta Tbk PT
IDX:NRCA
|
ID |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
Springfield Properties PLC
LSE:SPR
|
UK |
|
LG Chem Ltd
KRX:051910
|
KR |
|
R
|
Robit Oyj
OMXH:ROBIT
|
FI |
|
WPG Holdings Ltd
TWSE:3702A
|
TW |
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
Baidu Inc
NASDAQ:BIDU
|
CN |
|
Charter Communications Inc
NASDAQ:CHTR
|
US |
|
Dillard's Inc
NYSE:DDS
|
US |
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
Intrinsic Value
The intrinsic value for Nusa Raya Cipta Tbk PT (NRCA) under the Base Case is hidden IDR. Compared with the current market price of 555 IDR, the stock appears hidden .
NRCA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether NRCA usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Nusa Raya Cipta Tbk PT.
Fundamental Analysis
Revenue & Expenses Breakdown
Nusa Raya Cipta Tbk PT
Earnings Waterfall
Nusa Raya Cipta Tbk PT
The intrinsic value for Nusa Raya Cipta Tbk PT (NRCA) under the Base Case is hidden IDR.
Compared with the current market price of 555 IDR, the stock appears hidden.